PR
Prime Medicine
PRME·NASDAQCambridge MAFounded 2019280 employees
Small CapbiotechPublicGenetic Medicine
Platform: Prime Editing
Market Cap
$1.2B
All Drugs
2
Clinical Trials
5
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (PRME)
Loading PRME stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| PRM-116 | PRM-116 | NDA/BLA | 2 | C5 | EoE | ||
| Tezeratamab | PRM-5051 | Phase 3 | 3 | CGRP | AsthmaThymoma |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (6)